Antibiotic treatment during an influenza infection actually impaired the body’s efforts to clear bacteria rather than helping the body heal.

Public health officials are concerned that we could move back into a situation like that of the early 20th century, before ...

Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with ...

The resistance of some infections to effective treatment with existing antibiotics ... of methicillin-resistant Staphylococcus aureus (MRSA) was identified. Resistance of certain bacteria to other ...

Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial ...

The history of antibiotic resistance in Staphylococcus ... that have prompted the development of newer agents for the treatment of MRSA disease. Moreover, the emergence of vancomycin-intermediate ...

The intravenous options for MRSA are generally ... varies with age. Treatment of infectious pulmonary exacerbations utilizes combinations of oral, inhaled and intravenous antibiotic agents.

it will be the first antibiotic in the beta-lactam class to or the treatment of SAB S. aureus, including hard-to-treat infections caused by methicillin-resistant strains (MRSA), said Basilea.

Scientists who developed the Oxford AstraZeneca vaccine during the Covid pandemic are developing the UK's first bubonic ...

The team behind the Oxford AstraZeneca covid vaccine say they are developing an injection that could prevent the bubonic ...

Oxford team reports hopeful results in trials as military experts say UK should stock supplies of Black Death inoculation ...